The Supreme Court of the United States ruled on Tuesday that providers cannot sue states over low Medicaid reimbursement rates, overturning the decision of the lower court.
The Supreme Court of the United States ruled on Tuesday that providers cannot sue states over low Medicaid reimbursement rates. The justices voted 5-4 in favor of the state of Idaho, which reversed a lower court’s ruling in the case of Armstrong v. Exceptional Child Center Inc.
The lawsuit, from 2009, claimed that Idaho was keeping Medicaid reimbursement rates at 2006 levels despite studies showing that the cost of providing care had increased since then. The 9th US Circuit Court of Appeals agreed in December 2013 with the providers and increased reimbursement costs in Idaho by an additional $12 million.
Idaho officials said the lawsuit would interfere with the state’s ability to fund Medicaid programs within set budgetary limits and 27 states filed legal papers in support of Idaho, according to the Associated Press.
Justice Antonin Scalia, writing the opinion of the court, said the providers have no right to sue the state. Instead, they can ask HHS to intervene on their behalf.
“We doubt that the Secretary’s notice to a State that its compensation scheme is inadequate will be ignored,” Justice Scalia wrote.
The providers claimed the right to sue the state under the Supremacy Clause of the Constitution, which holds that federal law generally trumps state law. However, all the justices agreed that “the Supremacy Clause does not provide an implied right of action, and that Congress may displace the equitable relief that is traditionally available to enforce federal law,” according to Justice Scalia. However, the disagreement stems from the conclusion that such displacement has occurred in this case.
Justices Sonia Sotomayor, Anthony M. Kennedy, Ruth Bader Ginsburg, and Elena Kagan were the dissenters. Justice Scalia delivered the opinion of the court with Justices Samuel Anthony Alito, Jr., Stephen G. Breyer, Clarence Thomas, and John G. Roberts, Jr.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Reducing Time Sitting Can Help Lower BP in Older Adults, Randomized Trial Finds
April 20th 2024The randomized trial found that reducing sitting time over a 6-month period was association with reduced systolic blood pressure (BP) among a group of older patients with obesity and high rates of hypertension.
Read More
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More